Lecanamab Ushers in a New Era of Anti-Amyloid Therapy for Alzheimer's Disease.

Musiek, Erik S; McDade, Eric; Holtzman, David M

Musiek, Erik S; McDade, Eric; Holtzman, David M.

Afiliación

Musiek ES; Department of Neurology, Hope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
McDade E; Department of Neurology, Hope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Holtzman DM; Department of Neurology, Hope Center for Neurological Disorders, and Knight Alzheimer Disease Research Center, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.

Ann Neurol ; 93(5): 877-880, 2023 05.

Article en En | MEDLINE | ID: mdl-36919987

Asunto(s)

Enfermedad de Alzheimer; Humanos; Enfermedad de Alzheimer/terapia; Péptidos beta-Amiloides; Amiloide

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Humans Idioma: En Revista: Ann Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google